Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma

Current Opinion in Pharmacology

Volumn 13, Issue 1, 2013, Pages 16-22

  Osborne, Neville N ^a   Del Olmo Aguado, Susana ^a  

^a Instituto Oftalmológico Fernandez Vega   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CATECHIN; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; IDEBENONE; MITOQ; NITROGEN OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; ROSIGLITAZONE; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; UBIDECARENONE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; DIET; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; ELECTRON TRANSPORT; ENERGY METABOLISM; GLAUCOMA; HOMEOSTASIS; HUMAN; INTRAOCULAR PRESSURE; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRION; NERVE EXCITABILITY; NERVE FIBER TRANSPORT; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; RETINA GANGLION CELL; SYNAPTIC TRANSMISSION;

EID: 84871286213     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.09.002     Document Type: Review

References (46)

1. M. Almasieh, A.M. Wilson, B. Morquette, J.L. Cueva Vargas, and A. Di Polo The molecular basis of retinal ganglion cell death in glaucoma Prog Retin Eye Res 31 2012 152 181
2. D.J. Calkins Critical pathogenic events underlying progression of neurodegeneration in glaucoma Prog Retin Eye Res 2012 Aug 1 [Epub ahead of print]
3. N.N. Osborne Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma Exp Eye Res 90 2010 750 757
4. D.C. Chan Mitochondria: dynamic organelles in disease, aging, and development Cell 125 2006 1241 1252
5. E.A. Schon, and G. Manfredi Neuronal degeneration and mitochondrial dysfunction J Clin Invest 111 2003 303 312
6. V. Carelli, F.N. Ross-Cisneros, and A.A. Sadun Mitochondrial dysfunction as a cause of optic neuropathies Prog Retin Eye Res 23 2004 53 89
7. P.J. Hollenbeck, and W.M. Saxton The axonal transport of mitochondria J Cell Sci 118 2005 5411 5419
8. J. Magrane, and G. Manfredi Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis Antioxid Redox Signal 11 2009 1615 1626
9. J. Flammer, S. Orgul, V.P. Costa, N. Orzalesi, G.K. Krieglstein, L.M. Serra, J.P. Renard, and E. Stefansson The impact of ocular blood flow in glaucoma Prog Retin Eye Res 21 2002 359 393
10. M. Mozaffarieh, M.C. Grieshaber, and J. Flammer Oxygen and blood flow: players in the pathogenesis of glaucoma Mol Vis 14 2008 224 233
11. N.N. Osborne, R.J. Casson, J.P. Wood, G. Chidlow, M. Graham, and J. Melena Retinal ischemia: mechanisms of damage and potential therapeutic strategies Prog Retin Eye Res 23 2004 91 147
12. S. Moncada, and J.P. Bolanos Nitric oxide, cell bioenergetics and neurodegeneration J Neurochem 97 2006 1676 1689
13. C.E. Cooper, and C. Giulivi Nitric oxide regulation of mitochondrial oxygen consumption. II: molecular mechanism and tissue physiology Am J Physiol Cell Physiol 292 2007 C1993 C2003
14. M. Palacios-Callender, V. Hollis, N. Frakich, J. Mateo, and S. Moncada Cytochrome c oxidase maintains mitochondrial respiration during partial inhibition by nitric oxide J Cell Sci 120 2007 160 165
15. C.E. Cooper, and G.C. Brown The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance J Bioenerg Biomembr 40 2008 533 539
16. C.T. Taylor, and S. Moncada Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia Arterioscler Thromb Vasc Biol 30 2010 643 647
17. N.N. Osborne, J. Melena, G. Chidlow, and J.P. Wood A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma Br J Ophthalmol 85 2001 1252 1259
18. N.N. Osborne, G. Lascaratos, A.J. Bron, G. Chidlow, and J.P. Wood A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies Br J Ophthalmol 90 2006 237 241
19. W.L. Yen, and D.J. Klionsky How to live long and prosper: autophagy, mitochondria, and aging Physiology 23 2008 248 262
20. S. Lee, N.J. Van Bergen, G.Y. Kong, V. Chrysostomou, H.S. Waugh, E.C. O'Neill, J.G. Crowston, and I.A. Trounce Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies Exp Eye Res 93 2011 204 212
21. G. Lascaratos, D.F. Garway-Heath, C.E. Willoughby, K.Y. Chau, and A.H. Schapira Mitochondrial dysfunction in glaucoma: understanding genetic influences Mitochondrion 12 2012 202 212
22. M. Aslan, A. Cort, and I. Yucel Oxidative and nitrative stress markers in glaucoma Free Radic Biol Med 45 2008 367 376
23. A. Baltmr, J. Duggan, S. Nizari, T.E. Salt, and M.F. Cordeiro Neuroprotection in glaucoma - is there a future role? Exp Eye Res 91 2010 554 566
24. G. Chidlow, J.P. Wood, and R.J. Casson Pharmacological neuroprotection for glaucoma Drugs 67 2007 725 759
25. L. Craggs, and R.N. Kalaria Revisiting dietary antioxidants, neurodegeneration and dementia Neuroreport 22 2011 1 3
26. M.P. Murphy, and R.A. Smith Targeting antioxidants to mitochondria by conjugation to lipophilic cations Annu Rev Pharmacol Toxicol 47 2007 629 656
27. P.H. Reddy, and M.F. Beal Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends Mol Med 14 2008 45 53
28. R.A. Smith, and M.P. Murphy Animal and human studies with the mitochondria-targeted antioxidant MitoQ Ann N Y Acad Sci 1201 2010 96 103
29. T. Klopstock, P. Yu-Wai-Man, K. Dimitriadis, J. Rouleau, S. Heck, M. Bailie, A. Atawan, S. Chattopadhyay, M. Schubert, and A. Garip A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy Brain 134 2011 2677 2686
30. R. Ritch Natural compounds: evidence for a protective role in eye disease Can J Ophthalmol 42 2007 425 438
31. M. Rhone, and A. Basu Phytochemicals and age-related eye diseases Nutr Rev 66 2008 465 472
32. B. Zhang, D. Rusciano, and N.N. Osborne Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro Brain Res 1198 2008 141 152
33. N.A. Kelsey, H.M. Wilkins, and D.A. Linseman Nutraceutical antioxidants as novel neuroprotective agents Molecules 15 2010 7792 7814
34. J. Clark, and D.K. Simon Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease Antioxid Redox Signal 11 2009 509 528
35. M.J. Calkins, D.A. Johnson, J.A. Townsend, M.R. Vargas, J.A. Dowell, T.P. Williamson, A.D. Kraft, J.M. Lee, J. Li, and J.A. Johnson The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease Antioxid Redox Signal 11 2009 497 508
36. N.N. Osborne Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria Prog Brain Res 173 2008 339 352
37. M.S. Schober, G. Chidlow, J.P. Wood, and R.J. Casson Bioenergetic-based neuroprotection and glaucoma Clin Experiment Ophthalmol 36 2008 377 385
38. N.N. Osborne, D. Ji, A.S. Abdul Majid, R.J. Fawcett, A. Sparatore, and P. Del Soldato ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture Invest Ophthalmol Vis Sci 51 2010 284 294
39. P.B. Pun, J. Lu, E.M. Kan, and S. Moochhala Gases in the mitochondria Mitochondrion 10 2010 83 93
40. A. Sparatore, E. Perrino, V. Tazzari, D. Giustarini, R. Rossi, G. Rossoni, K. Erdmann, H. Schroder, and P. Del Soldato Pharmacological profile of a novel H(2)S-releasing aspirin Free Radic Biol Med 46 2009 586 592
41. D. Giustarini, P. Del Soldato, A. Sparatore, and R. Rossi Modulation of thiol homeostasis induced by H2S-releasing aspirin Free Radic Biol Med 48 2010 1263 1272
42. N.N. Osborne, D. Ji, A.S. Majid, P. Del Soldata, and A. Sparatore Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14) Neurochem Int 60 2012 365 378
43. P.I. Moreira, M.S. Santos, R. Seica, and C.R. Oliveira Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes J Neurol Sci 257 2007 206 214
44. N. Schintu, L. Frau, M. Ibba, P. Caboni, A. Garau, E. Carboni, and A.R. Carta PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease Eur J Neurosci 29 2009 954 963
45. L. Cui, H. Jeong, F. Borovecki, C.N. Parkhurst, N. Tanese, and D. Krainc Transcriptional repression of PGC-1alpha by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 127 2006 59 69
46. E. Lavik, M.H. Kuehn, and Y.H. Kwon Novel drug delivery systems for glaucoma Eye (Lond) 25 2011 578 586